Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 23;9(1):92.
doi: 10.1186/s41927-025-00546-3.

Metabolomics in spondylarthritis

Susann Patschan  1 , Constantin Remus  1 , Inga Claus  1 , Meike Hoffmeister  2   3 , Oliver Ritter  1   3 , Daniel Patschan  4   5
Affiliations

Metabolomics in spondylarthritis

Susann Patschan et al. BMC Rheumatol. .

Abstract

Background and aim: Spondyloarthritides (SpA) are common entities of the inflammatory rheumatic type. There are still 3 relevant problems in everyday clinical practice: early disease detection, cardiovascular risk assessment, and less so, disease activity measurement. Metabolomics allows the quantification of a large number of small-molecule substances from biological samples.

Methods: The following databases were searched for references: PubMed, Web of Science, Cochrane Library, Scopus. The period lasted from 1973 until 2024.

Results: Finally, 14 analyses were identified. Most studies have evaluated patients with established disease. Some studies were able to un-mask metabolomic characteristics of certain forms of SpA. Approaches that utilize an integrative view of several metabolites in combination with general patient characteristics appear to be quite promising. Such approaches are suitable, for example, for assessing activity in psoriatic arthritis (PsA) or evaluating cardiovascular risk in individuals with psoriatic disease.

Conclusions: Metabolomics are helpful in identifying new diagnostic and predictive parameters in SpA, so far mainly in PsA. An almost consistent limitation of the studies to date is the inclusion of patients with already manifest disease.

Keywords: Cardiovascular risk; Disease activity; Metabolomics; SpA.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval andconsent to participate: The study did not require ethical approval. Consent for publication: Not applicable. Conflict of interest: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Search approach and the number of references obtained
See this image and copyright information in PMC

References

    1. Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, et al. The assessment of SpondyloArthritis International society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011, Jan;70(1):25–31. - PubMed
    1. Braun J. Axial spondyloarthritis: Thoughts about nomenclature and treatment targets. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S132–135. - PubMed
    1. Akkoc N, Khan MA. Is axial spondyloarthritis more common than rheumatoid arthritis? Curr Rheumatol Rep. 2020, Sep;22(9):54. - PubMed
    1. Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022, Oct;18(10):591–602. - PubMed
    1. Poddubnyy D. Classification vs diagnostic criteria: The challenge of diagnosing axial spondyloarthritis. Rheumatol Oxf Engl. 2020, Oct 1;59(Suppl4):iv6–17. - PMC - PubMed

LinkOut - more resources